I am a
Home I AM A Search Login

Papers of the Week


2022 Mar 19


Mult Scler Relat Disord


61

Finnish multiple sclerosis patients treated with cladribine tablets: a nationwide registry study.

Authors

Rauma I, Viitala M, Kuusisto H, Atula S, Sipilä JOT, Ryytty M, Soilu-Hänninen M, Järvinen E
Mult Scler Relat Disord. 2022 Mar 19; 61:103755.
PMID: 35483129.

Abstract

Cladribine tablets for adult patients with highly active relapsing multiple sclerosis (MS) have been available in Finland since 2018. Real-world data from different genetic and geographical backgrounds are needed to complement data from clinical trials.